Category : Search result: PCD pharma franchise


Mavericks to Honor Mark Aguirre in Historic Tribute

Dallas Mavericks set to pay long-overdue tribute to Mark Aguirre, the scoring machine who shaped the franchise's early history. Discover the emotional homecoming planned for the basketball icon.

Halo Jumps to PlayStation After 25 Years

In a groundbreaking industry shift, Microsoft's flagship Halo franchise is coming to PlayStation for the first time ever with the enhanced Halo: Combat Evolved campaign, ending 25 years of Xbox exclusivity.

Mukul Agrawal's ₹200 Cr Pharma Stock Bet Revealed

Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.

Dr. Reddy's Legacy: Transforming Indian Pharma

Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.

Stree 3 Delayed: Dinesh Vijan Reveals Why

Producer Dinesh Vijan explains why Stree 3 is skipping 2026 release date. Discover the creative reasons behind the delay and what makes the horror-comedy franchise special.

TN Couple Arrested in ATM Franchise Scam

Coimbatore police nab couple behind sophisticated ATM franchise scam that duped investors of lakhs. Exclusive details on their elaborate con operation.

Sigachi Q2: Profit Halves, Revenue Down 19%

Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?

Aurobindo Pharma Expands to Chile with New Subsidiary

Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.

Torrent Pharma gets CCI nod for JB Chemicals stake

In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.

Indian Pharma Wins Crucial Legal Battle for Generic Drugs

A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.

Ayan Mukerji Exits Dhoom 4 - YRF Seeks New Director

In a shocking turn for Bollywood, Ayan Mukerji steps down as director of the much-anticipated Dhoom 4. Yash Raj Films now faces the challenge of finding a replacement for the blockbuster franchise.

Varun Beverages Q3 Results Date Announced

Varun Beverages Ltd announces crucial board meeting to review Q3 FY2025 financial results. Get exclusive insights on date, dividend possibilities, and market expectations for Pepsi's largest Indian franchisee.

Novo Nordisk Board Reshuffle: New Faces at the Helm

Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.

Zydus vs Rubicon: Pharma Stock Analysis

Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.

Rajat Bedi Addresses Krrish 4 Casting Rumours

Bollywood actor Rajat Bedi addresses swirling speculation about his involvement in the highly anticipated Krrish 4, revealing fan expectations and his own hopes for the superhero franchise.

MP SIT to Make More Arrests in Pharma Tragedy

Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.

Supreme Court allows generic SMA drug in blow to Roche

In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.

Bob Myers Shocks Sports World With ESPN Exit

Former Golden State Warriors architect Bob Myers leaves ESPN to join a private equity firm, signaling a seismic shift in how sports franchises are built and valued globally.

Page 4 of 4